We are live on ! Find out more
CLRBZ

Cellectar Biosciences, Inc. Series A Warrants
CLRBZ

Delisted

CLRBZ was delisted on the 16th of April, 2021.

Back to rankings

3 hedge funds and large institutions have $171K invested in Cellectar Biosciences, Inc. Series A Warrants in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding

Funds holding: 2 → 3 (+1)

27% less capital invested

Capital invested by funds: $233K → $171K (-$62K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
+$23.1K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$2.83K
2
UBS Group
UBS Group
Switzerland
-$1.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$147K -$2.83K -4,500 -2%
VKH
2
Virtu KCG Holdings
New York
$22K +$23.1K +36,838 New
UBS Group
3
UBS Group
Switzerland
$2K -$1.7K -2,700 -45%

CLRBZ Hedge Fund Activity: Q2 2017 in Review

3 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) for Q2 2017, worth a combined $171K — down 27% from $233K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new CLRBZ positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.

The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $23.1K. The largest seller was Susquehanna International Group, cutting an estimated $2.83K.

  • 3 institutional investors held Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) as of Q2 2017, up from 2 in Q1 2017.
  • Funds reported $171K of Cellectar Biosciences, Inc. Series A Warrants stock for Q2 2017, down 27% quarter-over-quarter.
  • 1 fund opened new Cellectar Biosciences, Inc. Series A Warrants positions in Q2 2017 and 0 closed out, a net change of +1 holder.
  • The largest Cellectar Biosciences, Inc. Series A Warrants buyer in Q2 2017 was Virtu KCG Holdings, an estimated $23.1K added.
  • The largest Cellectar Biosciences, Inc. Series A Warrants seller in Q2 2017 was Susquehanna International Group, an estimated $2.83K sold.

Based on aggregated 13F filings for Q2 2017.